Stira Pharmaceuticals

Executive Summary

Stira Pharmaceuticals is a U.S.-based Contract Development and Manufacturing Organization (CDMO) headquartered in San Diego, specializing in complex sterile injectable products. Founded in 2020, the company offers integrated, end-to-end support from pre-formulation through clinical and commercial manufacturing across multiple modalities including small molecules, peptides, oligonucleotides, and large molecules/biosimilars. By focusing on the U.S. market and providing high-quality analytical services and development capabilities, Stira aims to address the growing demand for specialized CDMO services in the injectable space. While still early-stage, the company's niche focus on complex sterile products positions it to capture partnerships with biotech and pharma firms seeking reliable manufacturing partners. As a private entity, financial details are limited, but the company's strategic location in San Diego's biotech hub may facilitate collaborations.

Upcoming Catalysts (preview)

• Q4 2026Announcement of Major Client Contract or Partnership40% success
• Q2 2027Completion of New Manufacturing Facility or Expansion50% success
• TBDFDA Certification or Regulatory Milestone30% success